JP2001513550A5 - - Google Patents

Download PDF

Info

Publication number
JP2001513550A5
JP2001513550A5 JP2000507355A JP2000507355A JP2001513550A5 JP 2001513550 A5 JP2001513550 A5 JP 2001513550A5 JP 2000507355 A JP2000507355 A JP 2000507355A JP 2000507355 A JP2000507355 A JP 2000507355A JP 2001513550 A5 JP2001513550 A5 JP 2001513550A5
Authority
JP
Japan
Prior art keywords
vaginal
suppository
following ingredients
vaginal suppository
combine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000507355A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001513550A (ja
Filing date
Publication date
Priority claimed from DE19737348A external-priority patent/DE19737348C2/de
Application filed filed Critical
Publication of JP2001513550A publication Critical patent/JP2001513550A/ja
Publication of JP2001513550A5 publication Critical patent/JP2001513550A5/ja
Pending legal-status Critical Current

Links

JP2000507355A 1997-08-27 1998-08-27 新規医薬組成物 Pending JP2001513550A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19737348A DE19737348C2 (de) 1997-08-27 1997-08-27 Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
DE19737348.8 1997-08-27
PCT/EP1998/005454 WO1999009964A2 (de) 1997-08-27 1998-08-27 Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektion

Publications (2)

Publication Number Publication Date
JP2001513550A JP2001513550A (ja) 2001-09-04
JP2001513550A5 true JP2001513550A5 (cg-RX-API-DMAC7.html) 2009-12-10

Family

ID=7840348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000507355A Pending JP2001513550A (ja) 1997-08-27 1998-08-27 新規医薬組成物

Country Status (7)

Country Link
US (1) US6537970B1 (cg-RX-API-DMAC7.html)
EP (1) EP1009414B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001513550A (cg-RX-API-DMAC7.html)
AT (1) ATE308328T1 (cg-RX-API-DMAC7.html)
AU (1) AU9534398A (cg-RX-API-DMAC7.html)
DE (2) DE19737348C2 (cg-RX-API-DMAC7.html)
WO (1) WO1999009964A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8709482B2 (en) 2004-08-05 2014-04-29 Ferring B.V. Stabilised prostaglandin composition

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
EP1421093B1 (en) * 2001-08-28 2005-06-29 Pharmacia Corporation Crystaline clindamycin free base
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
EP1572201B1 (en) * 2002-12-18 2008-07-09 Ferrer Internacional, S.A. Pharmaceutical compositions of sertaconazole for vaginal use
MXPA05008571A (es) * 2005-08-12 2007-02-12 Leopoldo Espinosa Abdala Formulaciones farmaceuticas solidas, semisolidas, en suspension, en solucion, en emulsion o en jarabe conteniendo clindamicina y uno o mas de los miembros de la familia de los azoles.
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
MX2009000053A (es) * 2006-07-12 2009-02-23 Controlled Therapeutics Sct Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US8603513B2 (en) * 2007-06-28 2013-12-10 The Procter & Gamble Company Article comprising calcium for reducing the production of TSST-1
EP2130531A1 (en) * 2008-06-04 2009-12-09 Rolf Kullgren AB Vaginal suppository comprising lactic acid
US20100285096A1 (en) * 2009-05-05 2010-11-11 Fancheng Wang Hygiene Article Having Calcium Sugar Phosphate
US20100285095A1 (en) * 2009-05-05 2010-11-11 Kimberly Ann Nemeth Hygiene Article Having Calcium Sugar Acid Salt
WO2011027247A1 (en) 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
WO2011101826A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, terbinafine and dexamethasone, and a process to make it
WO2012049542A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, mometasone as a corticosteroid and clotrimazol as antifungal agent, and a process to make it
WO2012049544A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a hydrocortisone acetate as a corticosteroid, and clotrimazole as an antifungal agent, and a process to make it
CN103830198B (zh) * 2012-11-28 2016-05-18 南京亿华药业有限公司 一种克霉唑阴道片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318853A (en) * 1980-01-31 1982-03-09 The Upjohn Company 9β,11β-Epoxy-5β-corticoids
US5160737A (en) 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8709482B2 (en) 2004-08-05 2014-04-29 Ferring B.V. Stabilised prostaglandin composition

Similar Documents

Publication Publication Date Title
JP2952505B2 (ja) 抗ウイルス性薬剤
JPS61106511A (ja) 抗真菌性医薬組成物
KR920021139A (ko) 약학 조성물
US20200054552A1 (en) Medicament for the treatment of viral skin and tumour diseases
FI89065C (fi) Foerfarande foer framstaellning av en ny siklosporin kristallform
US12357655B2 (en) Polyglutamic acid compositions and methods of using
RU2012127436A (ru) Фармацевтическая композиция для местного применения, способ местного вагинального введения и способ профилактики инфицирования вич с ее помощью, презерватив ее содержащий, лекарственное средство (варианты) и способ профилактики заболеваний, передающихся половым путем
ITMI952221A1 (it) Composizioni farmaceutiche solide per uso vaginale
CZ291237B6 (cs) Farmaceutický přípravek pro orální podání obsahující cyklosporin A
EP0308564B1 (fr) Composition inhibitrice ou destructrice d'au moins un être vivant unicellulaire renfermant un fluorure d'ammononium quaternaire et procédé de préparation de ce sel
JP2024544415A5 (cg-RX-API-DMAC7.html)
JPH10503194A (ja) 多くの異なる活性成分を含有する医薬組成物、主として腟座薬
LT4441B (lt) Antigliukokortikoidinis vaistinis preparatas
CN102525883A (zh) 一种伏立康唑栓剂及其制备方法和用途
WO2002004012A1 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
CZ20021433A3 (cs) Proléčivo na bázi 6-methoxy-2-naftyloctové kyseliny
CN120225182A (zh) 内瑟顿综合征的联合治疗
JP5743375B2 (ja) カンジダ症予防又は治療剤
WO2021099901A1 (en) Stable topical pharmaceutical composition
RU2205011C1 (ru) Фармацевтическая композиция с антибактериальной активностью
JPH04210631A (ja) 消化管壁保護剤
JP2023506598A5 (cg-RX-API-DMAC7.html)
JPH0769883A (ja) アロマターゼ阻害剤
JPH01249720A (ja) 座薬
CZ269293A3 (en) Medicinal ointment without skin irritating effect and process for preparing thereof